One year later: The head of Johnson & Johnson China looks back on what we’ve learned from the pandemic—and how it can help shape the future
Will Song’s teams were on the front lines when COVID-19 shut down the city of Wuhan. One year to the day that the World Health Organization declared the disease a pandemic, he shares how the company kept going during the crisis and the innovative ideas that emerged from it.
From lab to vaccine vial: The historic manufacturing journey of Johnson & Johnson’s Janssen COVID-19 Vaccine
As the U.S. government announces an agreement between Johnson & Johnson and Merck to collaborate on vaccine production, we trace all the steps it takes—from growing cells in a bioreactor to prepping palettes with high-tech track-and-trace technology—to develop and manufacture a vaccine during a pandemic.
A message from Chairman and CEO Alex Gorsky about the Emergency Use Authorization of Johnson & Johnson’s Janssen COVID-19 vaccine
The company leader shares the latest news about the U.S. Food and Drug Administration’s decision about the single-shot Janssen COVID-19 vaccine.
Driving change: How Johnson & Johnson is using mobile healthcare to help address health inequities across the U.S.
From churches to schools—and even roving healthcare vans—the company has rolled out a program in states across the nation to help get COVID-19 testing and other crucial health services to underserved communities.
“COVID-19 inspired me to improve patient care": How two nurses devised new ways to help kids and fellow nurses during the pandemic
From a virtual reality game that helps children with remote physical therapy to a clever way to upgrade personal protective equipment for healthcare workers, the winning ideas from the latest Johnson & Johnson Nurses Innovate QuickFire Challenge came out of medical conundrums posed by the pandemic. Meet the women behind them.
The Access to Medicine Index, a ranking of pharmaceutical companies’ work to distribute medications to low- and middle-income countries, just named Johnson & Johnson #3 on its biennial list, underscoring the company’s deep history of ensuring people in underserved communities receive the treatments they need.
“My 2021 healthcare resolution": 7 Johnson & Johnson leaders share their goals for advancing healthcare and health equity
A potential COVID-19 vaccine. Passionate efforts toward achieving racial and social justice. Smarter, more sustainable product packaging. These are just a few of the resolutions company change makers are aiming to bring to light this year—and they’re already hard at work on them.
The COVID-19 data plan: 3 innovative ways Johnson & Johnson is using data science to fight the pandemic
Tracking the spread of the virus in real time. Analyzing data to learn more about who’s most vulnerable. These are just a couple of ways the company’s data science team is helping inform how to respond to the pandemic.
As the J.P. Morgan Healthcare Conference takes place this week, the President of Johnson & Johnson Innovation – JJDC, Inc. shares some of the scientific breakthroughs and collaborations his team is championing to help address the unmet needs and well-being of people around the world.